Yamo Pharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.yamopharma.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Yamo Pharmaceuticals LLC
- Target Recruit Count
- 58
- Registration Number
- NCT05067582
- Locations
- 🇺🇸
Southwest Autism Research and Resource Center, Phoenix, Arizona, United States
🇺🇸Thompson Autism Center CHOC, Orange, California, United States
🇺🇸Cortica, San Rafael, California, United States
Safety of L1-79 in Adolescent and Adult Males With Autism
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Yamo Pharmaceuticals LLC
- Target Recruit Count
- 42
- Registration Number
- NCT02947048
- Locations
- 🇺🇸
Eric Bartky MD, Bartky Health Care Center, Livingston, New Jersey, United States
🇺🇸F. Peter Halas MD, Sea Girt Pediatrics, Sea Girt, New Jersey, United States
News
No news found